ASPC 2019 Congress on CVD Prevention

 

ASPC 2019 Congress on CVD Prevention
Avatar

Rebranding and Rehabilitating Cardiac Rehabilitation in 2019

By ASPC 2019 Congress on CVD Prevention FEATURING Pam Taub
August 12, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

01:13
Novo Nordisk – GLP-1 RA Therapy

ADA Guidelines for T2D: What Is the Preferred Next Step After Oral A…

Feat. C. Wierum, L. Coco

Featured Video

01:52
Novo Nordisk – GLP-1 RA Therapy

T2D Treatment After Oral Agents: What Is the Next Step?

Feat. C. Wierum, L. Coco
Session 8: Potpourri II
22:52
ASPC 2019 Congress on CVD Prevention

Revascularization in Stable Ischemic Heart Disease - It Is Prevalent…

11:16
ASPC 2019 Congress on CVD Prevention

Wearable Technologies: An Untapped Opportunity in Healthcare

30:58
ASPC 2019 Congress on CVD Prevention

Tobacco Cessation and Cardiovascular Hazards of Vaping

Feat. P. Morris
27:57
ASPC 2019 Congress on CVD Prevention

Rebranding and Rehabilitating Cardiac Rehabilitation in 2019

Feat. P. Taub
30:47
ASPC 2019 Congress on CVD Prevention

Exercise and Cardiovascular Health: How Much and What Kind?